NCT Number: NCT04943536
Phase: Phase 1
Trial Summary: This study will be undertaken to evaluate the feasibility of replacing systemic Androgen Deprivation Therapy (ADT) with targeted local delivery of an anti-androgen agent alone in p – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Alessa Therapeutics Inc.
Acronym: BiolenRT
Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives